Article
A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer
28 Dec 2024
Abstract excerpt
Endometrial cancer is the most prevalent form of gynecologic malignancy, with a significant surge in incidence among youngsters. Although the advent of the immunotherapy era has profoundly improved patient outcomes, not all patients benefit from immunotherapy; some patients experience hyperprogression while on immunotherapy. Hence, there is a pressing need to further delineate the distinct immune response...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
